Literature DB >> 17333742

Patterns of Helicobacter pylori isolate resistance to fluoroquinolones, amoxicillin, clarithromycin and metronidazoles.

Widyasari Kumala1, Aziz Rani.   

Abstract

Helicobacter pylori eradication using the three antibiotic regimen of amoxicillin, clarithromycin and metronidazole often fails, making it imperative to find substitutes. The following study made use of 72 H. pylori isolates derived from pyloric antrum mucosa biopsies of gastritis and chronic dyspepsia patients treated at the Cipto Mangunkusumo National General Hospital and three private hospitals in Jakarta. Testing for H. pylori sensitivity to various antimicrobials was conducted using the disk diffusion method (Kirby Bauer) and procedures determined by the Clinical and Laboratory Standards Intitute (CLSI)/NCCLS. The resistance rates of the isolates were 100% for metronodazole, 27.8% for clarithromycin, 19.4% for amoxicillin, 6.9% for ciprofloxacin, norfloxacin and ofloxacin, 2.8% for sparfloxacin and gatifloxacin, and 1.4% for levofloxacin and moxifloxacin. Fluoroquinolons have the lowest resistance compared to amoxicillin, clarithromycin and metronidazole.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17333742

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  15 in total

1.  Second-line rescue therapy of helicobacter pylori infection.

Authors:  Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

Review 2.  "Rescue" regimens after Helicobacter pylori treatment failure.

Authors:  Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

3.  Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran.

Authors:  Shohreh Farshad; Abdolvahab Alborzi; Aziz Japoni; Reza Ranjbar; Kazem Hosseini Asl; Parisa Badiee; Maneli Amin Shahidi; Marziyeh Hosseini
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

4.  Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori.

Authors:  Kathleen R Jones; Jeong-Heon Cha; D Scott Merrell
Journal:  Curr Drug ther       Date:  2008-09-01

5.  In vitro antibacterial activity of nimbolide against Helicobacter pylori.

Authors:  Marina R Wylie; Ian H Windham; Faith C Blum; Hannah Wu; D Scott Merrell
Journal:  J Ethnopharmacol       Date:  2021-11-09       Impact factor: 4.360

6.  Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial.

Authors:  Josip Bago; Karolina Majstorović; Zeljka Belosić-Halle; Nastja Kućisec; Vinko Bakula; Monika Tomić; Petra Bago; Rosana Troskot
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-04-15       Impact factor: 3.944

7.  Drug utilization of clarithromycin for gastrointestinal disease treatment.

Authors:  Quan Zhou; Ling-Ling Zhu; Xiao-Feng Yan; Wen-Sheng Pan; Su Zeng
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

8.  Antibiotic susceptibility profile of Helicobacter pylori isolated from the dyspepsia patients in Tehran, Iran.

Authors:  Leila Shokrzadeh; Fereshteh Jafari; Hossein Dabiri; Kaveh Baghaei; Homayoun Zojaji; Amir H Alizadeh; Mohammad Mehdi Aslani; Mohammad R Zali
Journal:  Saudi J Gastroenterol       Date:  2011 Jul-Aug       Impact factor: 2.485

9.  Rescue Therapy for Helicobacter pylori Infection 2012.

Authors:  Javier P Gisbert
Journal:  Gastroenterol Res Pract       Date:  2012-02-28       Impact factor: 2.260

10.  Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran.

Authors:  Farzad Khademi; Jamshid Faghri; Farkhondeh Poursina; Bahram Nasr Esfahani; Sharareh Moghim; Hossein Fazeli; Peyman Adibi; Nasrin Mirzaei; Mojtaba Akbari; Hajieh Ghasemian Safaei
Journal:  J Res Med Sci       Date:  2013-12       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.